Yoneda Labs, a San Francisco, CA-based AI powered drug discovery startup, raised $4M in Seed funding.
Backers included Khosla Ventures, 500 Emerging Europe, 468 Capital, Fellows Fund, and Y Combinator.
The company intends to use the funds to expand its development efforts.
Founded by Michal Mgeladze-Arciuch, Jan Oboril, and Daniel Vlasits, Yoneda Labs is building a foundation AI chemical manufacturing model for chemists working in drug discovery.
The Y Combinator (YC) startup is building a foundation model for chemists working in drug discovery
During their time at YC, the team identified 20,000 chemical reactions to generate proprietary data for their foundation model. In a small-scale trial, the models suggested good conditions in 95% of cases, a stark improvement to the industry standard in which the majority of the experiments fail.
With this funding, they plan to build out a robotics lab capable of running experiments on the remaining 20,000 reactions to continue training a generalizable AI model for chemists. Later this year, they plan to be able to run and analyze 200 experiments a day, the equivalent output of roughly 20 full-time chemists.
About
| Advertise
| Contact
| Terms & Conditions
| Privacy Policy
| Disclaimer
| The Daily Deal Newsletter
FinSMEs Ltd – 86 – 90 Paul Street – London, UK – EC2A 4NE – e-mail: [email protected]